Literature DB >> 31803816

Persistence of antibody response in chikungunya.

Shweta Chelluboina1, S Robin1, S Aswathyraj1, G Arunkumar1.   

Abstract

Chikungunya is a mosquito-borne viral illness associated with chronic arthritic symptoms that persist for months. The IgM antibody appears within a week post any infection and declines at 2-3 months. The present study was aimed to demonstrate the presence of specific IgM antibody among chikungunya confirmed cases. Blood samples were collected from chikungunya PCR positive patients at the time of diagnosis, at 1-week, 1, 8, 10 and 12 months post infection. All acute and follow-up serum samples were evaluated for chikungunya virus-specific IgM antibodies using ELISA technique. Our findings indicate the persistence of anti-chikungunya IgM up to 10-months post-infection in a majority of chikungunya virus infected persons. Interpretation of results should be carefully done as only IgM ELISA is used to diagnose acute infection, especially post chikungunya outbreak. The presence of IgM antibody does not rule out the absence of any other diagnosis due to its persistence. Thus, we hypothesize that real-time PCR is more reliable for the detection of acute chikungunya cases in endemic areas while IgM detection may be useful in identifying exposure to this disease. © Indian Virological Society 2019.

Entities:  

Keywords:  Chikungunya; Follow-up; Neutralising antibodies; Persisting antibodies

Year:  2019        PMID: 31803816      PMCID: PMC6863990          DOI: 10.1007/s13337-019-00534-5

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  12 in total

Review 1.  Chikungunya: a re-emerging virus.

Authors:  Felicity J Burt; Micheal S Rolph; Nestor E Rulli; Suresh Mahalingam; Mark T Heise
Journal:  Lancet       Date:  2011-11-17       Impact factor: 79.321

2.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  French guidelines for the management of chikungunya (acute and persistent presentations). November 2014.

Authors:  F Simon; E Javelle; A Cabie; E Bouquillard; O Troisgros; G Gentile; I Leparc-Goffart; B Hoen; F Gandjbakhch; P Rene-Corail; J-M Franco; E Caumes; B Combe; S Poiraudeau; F Gane-Troplent; F Djossou; T Schaerverbeke; A Criquet-Hayot; P Carrere; D Malvy; P Gaillard; D Wendling
Journal:  Med Mal Infect       Date:  2015-06-25       Impact factor: 2.152

4.  Estimation of dengue virus IgM persistence using regression analysis.

Authors:  Harry E Prince; Jose L Matud
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

5.  Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study.

Authors:  A Chopra; V Anuradha; R Ghorpade; M Saluja
Journal:  Epidemiol Infect       Date:  2011-07-18       Impact factor: 2.451

6.  Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.

Authors:  Olayinka M Olajiga; Olajumoke E Adesoye; Adewale P Emilolorun; Abiodun J Adeyemi; Emmanuel O Adeyefa; Ismail A Aderibigbe; Salmot A Adejumo; Wasiu O Adebimpe; Oluyinka O Opaleye; Waidi F Sule; Daniel O Oluwayelu
Journal:  Immunol Invest       Date:  2017-07-25       Impact factor: 3.657

7.  Molecular and serological diagnosis of Chikungunya virus infection.

Authors:  P Grivard; K Le Roux; P Laurent; A Fianu; J Perrau; J Gigan; G Hoarau; N Grondin; F Staikowsky; F Favier; A Michault
Journal:  Pathol Biol (Paris)       Date:  2007-10-24

8.  A case of chikungunya fever imported from India to Japan, follow-up of specific IgM and IgG antibodies over a 6-month period.

Authors:  Ikuko Aoyama; Kenji Uno; Takahiro Yumisashi; Tomohiko Takasaki; Chang-Kweng Lim; Ichiro Kurane; Tetsuo Kase; Kazuo Takahashi
Journal:  Jpn J Infect Dis       Date:  2010-01       Impact factor: 1.362

9.  Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy.

Authors:  A Pierro; G Rossini; P Gaibani; A C Finarelli; M L Moro; M P Landini; V Sambri
Journal:  New Microbes New Infect       Date:  2015-04-15

10.  Persisting mixed cryoglobulinemia in Chikungunya infection.

Authors:  Manuela Oliver; Marc Grandadam; Catherine Marimoutou; Christophe Rogier; Elisabeth Botelho-Nevers; Hugues Tolou; Jean-Luc Moalic; Philippe Kraemer; Marc Morillon; Jean-Jacques Morand; Pierre Jeandel; Philippe Parola; Fabrice Simon
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more
  7 in total

Review 1.  A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.

Authors:  Thaise Yasmine Vasconcelos de Lima Cavalcanti; Mylena Ribeiro Pereira; Sergio Oliveira de Paula; Rafael Freitas de Oliveira Franca
Journal:  Viruses       Date:  2022-05-05       Impact factor: 5.818

2.  Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?

Authors:  Monique da Rocha Queiroz Lima; Raquel Curtinhas de Lima; Elzinandes Leal de Azeredo; Flavia Barreto Dos Santos
Journal:  Diagnostics (Basel)       Date:  2021-04-30

3.  "Kankasha" in Kassala: A prospective observational cohort study of the clinical characteristics, epidemiology, genetic origin, and chronic impact of the 2018 epidemic of Chikungunya virus infection in Kassala, Sudan.

Authors:  Hilary Bower; Mubarak El Karsany; Abd Alhadi Adam Hussein Adam; Mubarak Ibrahim Idriss; Ma'aaza Abasher Alzain; Mohamed Elamin Ahmed Alfakiyousif; Rehab Mohamed; Iman Mahmoud; Omer Albadri; Suha Abdulaziz Alnour Mahmoud; Orwa Ibrahim Abdalla; Mawahib Eldigail; Nuha Elagib; Ulrike Arnold; Bernardo Gutierrez; Oliver G Pybus; Daniel P Carter; Steven T Pullan; Shevin T Jacob; Tajeldin Mohammedein Abdallah; Benedict Gannon; Tom E Fletcher
Journal:  PLoS Negl Trop Dis       Date:  2021-04-30

4.  Long-Term Persistence of Serum-Specific Anti-Chikungunya IgM Antibody - A Case Series of Brazilian Patients.

Authors:  Denise Maria do Nascimento Costa; Maria Rosângela Cunha Duarte Coêlho; Pedro Alves da Cruz Gouveia; Luan Araújo Bezerra; Claudia Diniz Lopes Marques; Angela Luzia Branco Pinto Duarte; Lucila Maria Valente; Vera Magalhães
Journal:  Rev Soc Bras Med Trop       Date:  2021-04-12       Impact factor: 1.581

5.  Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection.

Authors:  Leile Camila Jacob-Nascimento; Caroline Xavier Carvalho; Monaíse Madalena Oliveira Silva; Mariana Kikuti; Rosângela Oliveira Anjos; Jordana Rodrigues Barbosa Fradico; Ana Carolina Campi-Azevedo; Laura Beatriz Tauro; Gúbio Soares Campos; Patricia Sousa Dos Santos Moreira; Moyra Machado Portilho; Olindo Assis Martins-Filho; Guilherme Sousa Ribeiro; Mitermayer Galvão Reis
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 6.  Human Genetic Host Factors and Its Role in the Pathogenesis of Chikungunya Virus Infection.

Authors:  Juan C Rueda; Mauricio Arcos-Burgos; Ana M Santos; Daniel Martin-Arsanios; Catalina Villota-Erazo; Viviana Reyes; Santiago Bernal-Macías; Ingris Peláez-Ballestas; Mario H Cardiel; John Londono
Journal:  Front Med (Lausanne)       Date:  2022-02-16

7.  Virological, Serological and Clinical Analysis of Chikungunya Virus Infection in Thai Patients.

Authors:  Yin May Tun; Prakaykaew Charunwatthana; Chatnapa Duangdee; Jantawan Satayarak; Sarocha Suthisawat; Oranit Likhit; Divya Lakhotia; Nathamon Kosoltanapiwat; Passanesh Sukphopetch; Kobporn Boonnak
Journal:  Viruses       Date:  2022-08-18       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.